Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.

Pediatrics

Volumn 110, Issue 3, 2002, Pages

  Turgay, Atilla ^a   Binder, Carin ^a   Snyder, Richard ^a   Fisman, Sandra ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN ANTAGONIST;

ARTICLE; BEHAVIOR DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; RANDOMIZED CONTROLLED TRIAL;

ANTIPSYCHOTIC AGENTS; CHILD; CHILD BEHAVIOR DISORDERS; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; MENTAL RETARDATION; RISPERIDONE; SEROTONIN ANTAGONISTS;

EID: 0036718143     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.110.3.e34     Document Type: Article

References (0)